MTOR and cancer: Notably, mTOR expression must be both cause and consequence, since its pharmacological inhibition results in the normoxic cancer cells upregulating a glucose transporter (GLUT2), and apparently switching to secrete rather than import lactate, resulting both in insufficient glucose for the hypoxic cells and likely toxic acidosis in the extracellular microenvironment.